Literature DB >> 11313336

Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells.

W G Butscher1, C M Haggerty, S Chaudhry, K Gardner.   

Abstract

In this report, we explore the mechanisms of targeting of p300 to the interleukin-2 (IL-2) promoter in response to mitogenic and oncogenic molecular signals. Recruitment of p300 by cAMP-responsive element-binding protein-Rel cross-talk at the composite CD28 response element (CD28RE)-TRE element of the IL-2 promoter is essential for promoter inducibility during T-cell activation, and CD28RE-TRE is the exclusive target of the human T-cell lymphotropic virus type I oncoprotein Tax. The intrinsic histone acetyltransferase activity of p300 is dispensable for activation of the IL-2 promoter, and the N-terminal 743 residues contain the minimal structural requirements for synergistic transactivation of the CD28RE-TRE, the IL-2 promoter, and endogenous IL-2 gene expression. Mutational analysis of p300 reveals differential structural requirements for the N-terminal p300 module by individual cis-elements within the IL-2 promoter. These findings provide evidence that p300 assembles at the IL-2 promoter to form an enhanceosome-like signal transduction target that is centrally integrated at the CD28RE-TRE element of the IL-2 promoter through specific protein module-targeted associations in activated T-cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313336     DOI: 10.1074/jbc.M009614200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.

Authors:  Jung S Byun; Madeline M Wong; Wenwu Cui; Gila Idelman; Quentin Li; Adriana De Siervi; Sven Bilke; Cynthia M Haggerty; Audrey Player; Yong Hong Wang; Michael J Thirman; Joseph J Kaberlein; Constantinos Petrovas; Richard A Koup; Dan Longo; Keiko Ozato; Kevin Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-30       Impact factor: 11.205

2.  BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.

Authors:  Valeriu B Cismasiu; Sailaja Ghanta; Javier Duque; Diana I Albu; Hong-Mei Chen; Rohini Kasturi; Dorina Avram
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

3.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Authors:  Christina G Katsiari; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

Review 4.  Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.

Authors:  Michael Bindhu; Amrithraj Nair; Michael D Lairmore
Journal:  Front Biosci       Date:  2004-09-01

5.  Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL.

Authors:  Yuri Pekarsky; Alexey Palamarchuk; Vadim Maximov; Alexey Efanov; Natalya Nazaryan; Urmila Santanam; Laura Rassenti; Thomas Kipps; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

6.  Long-Range Transcriptional Control of the Il2 Gene by an Intergenic Enhancer.

Authors:  Parul Mehra; Andrew D Wells
Journal:  Mol Cell Biol       Date:  2015-09-08       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.